FDA Advisory Meeting Breaks Out Into Conflict After Vote to Authorize Covid Vaccines for Young Children

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VBRPAC) meeting on Tuesday broke into conflict over a question that is polarizing the nation: Should children as young as five years old be getting the Covid vaccines?

The VRBPAC meeting encountered significant pushback over the FDA’s insistence on the language used to recommend vaccines for children between 5 and 11 years old. The vote, however, was 17 to 0 in favor with one exemption.

“Based on the totality of scientific evidence available, do the benefits of the Pfizer- BioNTech Covid-19 vaccine when administered as a 2-dose series (10 micrograms each dose, 3 weeks apart) outweigh its risks for use in children 5-11 years of age?”

Continue Reading HERE

Leave a Reply

Your email address will not be published. Required fields are marked *